Phenytoin and carbamazepine decrease oral bioavailability of praziquantel

P. R. M. Bittencourt, C. M. Gracia, Rand Randall Martins, A. G. Fernandas, H. W. Diekmann, W. Jung

Neurology · 1992 · 97 citations · 0 references

Concepts

Abstract

Antiepileptic drugs, especially carbamazepine and phenytoin, are potent liver enzyme inducers. Since praziquantel, the drug used to treat neurocysticercosis, undergoes extensive liver first-pass metabolism, we carried out a prospective study to verify whether there was a decrease in oral bioavailability induced by carbamazepine and phenytoin. Carbamazepine and phenytoin significantly decreased concentrations of praziquantel, due to increased clearance secondary to induction of first pass-liver metabolism. The magnitude of the decrease is surprisingly high and may be responsible for failures of treatment.